Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
38 (15%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-06-17 | 2021-07-22 | 141113 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-08-27 | 2021-09-30 | 144760 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-09-30 | 2021-11-05 | 146469 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-10-07 | 2021-11-05 | 146856 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-12-17 | 2022-01-20 | 151468 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-01-27 | 2022-02-25 | 153727 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2022-06-09 | 2022-09-08 | 162303 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-02-16 | 2023-06-09 | 184934 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-06-16 | 2023-07-21 | 195039 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-06-16 | 2023-10-04 | 195055 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-07-27 | 2023-08-04 | 200210 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2023-08-17 | 2023-10-04 | 202228 |
TEVA-SUCRALFATE | 1G | TABLET | Actual shortage | 2023-12-14 | 2024-05-16 | 213368 |
TEVA-SUCRALFATE | 1G | TABLET | Actual shortage | 2024-03-07 | 2024-04-25 | 221540 |
TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2017-08-02 | 2017-11-07 | 18021 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-03-26 | 2020-04-23 | 109574 |
TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110785 |
TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-09-03 | 2021-02-05 | 123738 |
TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 128022 |
TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-03-24 | 2022-04-21 | 157262 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |